Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SNDA
|
Brandon Ribar
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 593 Reduced 0.87% |
$19,794
$33.38 p/Share
|
Mar 24
2022 |
|
SNDA
|
Michael Fryar
SVP-Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 444 Reduced 1.18% |
$14,821
$33.38 p/Share
|
Mar 24
2022 |
|
SNDA
|
Kimberly Herman
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,457 Reduced 1.24% |
$48,635
$33.38 p/Share
|
Mar 24
2022 |
|
CYRN
|
Bruce Harold Johnson
Vice President of Sales |
SELL
Open market or private sale
|
Direct | 2,343 Reduced 0.67% |
$18,041
$7.7 p/Share
|
Mar 24
2022 |
|
CYRN
|
Michael Fleck
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 101 Reduced 0.03% |
$778
$7.7 p/Share
|
Mar 24
2022 |
|
CYRN
|
Eva Lilias Markowitz
VP, Human Resources |
SELL
Open market or private sale
|
Direct | 2,343 Reduced 0.6% |
$18,041
$7.7 p/Share
|
Mar 24
2022 |
|
CYRN
|
Michael Tamir
CISO and Vice President |
SELL
Open market or private sale
|
Direct | 3,012 Reduced 0.62% |
$23,192
$7.7 p/Share
|
Mar 24
2022 |
|
EPM
|
Ryan Stash
SVP & CFO |
SELL
Open market or private sale
|
Direct | 4,870 Reduced 2.27% |
$26,980
$5.54 p/Share
|
Mar 24
2022 |
|
MBII
|
Pamela G Marrone
Director |
SELL
Open market or private sale
|
Direct | 22,728 Reduced 1.01% |
$25,228
$1.11 p/Share
|
Mar 24
2022 |
|
MBII
|
Pamela G Marrone
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 0.88% |
$16,000
$0.8 p/Share
|
Mar 24
2022 |
|
XAIR
|
Robert Carey
Director |
BUY
Open market or private purchase
|
Direct | 3,685 Added 0.7% |
$24,247
$6.58 p/Share
|
Mar 24
2022 |
|
CECE
|
Todd R Gleason
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,776 Added 0.92% |
$9,875
$5.56 p/Share
|
Mar 24
2022 |
|
MNMD
|
Dan Karlin
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 950,000 Added 18.74% |
-
|
Mar 24
2022 |
|
MNMD
|
Miri Halperin Wernli
Executive President |
BUY
Grant, award, or other acquisition
|
Direct | 600,000 Added 32.0% |
-
|
Mar 24
2022 |
|
MNMD
|
Cynthia W. Hu
Chief Legal Officer&Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 1,200,000 Added 50.0% |
-
|
Mar 24
2022 |
|
LE
|
Peter L Gray
PRES LE Licensing, CAO & GC |
SELL
Payment of exercise price or tax liability
|
Direct | 6,484 Reduced 7.46% |
$118,917
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
Peter L Gray
PRES LE Licensing, CAO & GC |
BUY
Grant, award, or other acquisition
|
Direct | 20,740 Added 19.26% |
-
|
Mar 24
2022 |
|
LE
|
Jerome Griffith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 39,586 Reduced 34.42% |
$726,007
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
Jerome Griffith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 86,642 Added 42.97% |
-
|
Mar 24
2022 |
|
LE
|
Bernard Louis Mc Cracken Iii
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,799 Reduced 10.22% |
$32,994
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
Bernard Louis Mc Cracken Iii
CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 5,494 Added 23.78% |
-
|
Mar 24
2022 |
|
LE
|
James F Gooch
President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 6,703 Reduced 5.98% |
$122,933
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
James F Gooch
President and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 25,316 Added 18.41% |
-
|
Mar 24
2022 |
|
LE
|
Sarah W. Rasmusen
CHIEF INNOVATION OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,151 Reduced 13.58% |
$57,789
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
Sarah W. Rasmusen
CHIEF INNOVATION OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 9,844 Added 29.79% |
-
|
Mar 24
2022 |
|
LE
|
Chieh Tsai
EVP, Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,710 Reduced 9.23% |
$86,381
$18.34 p/Share
|
Mar 24
2022 |
|
LE
|
Chieh Tsai
EVP, Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,753 Added 26.87% |
-
|
Mar 24
2022 |
|
STRC
|
Benjamin G Wolff
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 503,499 Reduced 9.49% |
$3,670,508
$7.29 p/Share
|
Mar 24
2022 |
|
HLTH
|
Ayub K Khattak
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 42,264 Reduced 0.36% |
$295,425
$6.99 p/Share
|
Mar 24
2022 |
|
HLTH
|
Clint Sever
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 34,754 Reduced 0.97% |
$242,930
$6.99 p/Share
|
Mar 24
2022 |
|
GEVO
|
William H Baum |
SELL
Open market or private sale
|
Direct | 90,000 Reduced 41.27% |
$396,000
$4.4 p/Share
|
Mar 24
2022 |
|
GEVO
|
Gary W. Mize |
SELL
Open market or private sale
|
Direct | 101,343 Reduced 39.98% |
$453,003
$4.47 p/Share
|
Mar 24
2022 |
|
GEVO
|
Gary W. Mize |
BUY
Open market or private purchase
|
Direct | 35,339 Added 12.24% |
$158,319
$4.48 p/Share
|
Mar 24
2022 |
|
CASS
|
Ralph W Clermont
Director |
BUY
Grant, award, or other acquisition
|
Direct | 350 Added 2.53% |
$12,974
$37.07 p/Share
|
Mar 24
2022 |
|
CASS
|
James J Lindemann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 350 Added 1.55% |
$12,974
$37.07 p/Share
|
Mar 24
2022 |
|
CASS
|
Sally H Roth
Director |
BUY
Grant, award, or other acquisition
|
Direct | 350 Added 8.63% |
$12,974
$37.07 p/Share
|
Mar 24
2022 |
|
CASS
|
Joseph D Rupp
Director |
BUY
Grant, award, or other acquisition
|
Direct | 350 Added 3.27% |
$12,974
$37.07 p/Share
|
Mar 24
2022 |
|
CASS
|
Frank Wicks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 350 Added 1.67% |
$12,974
$37.07 p/Share
|
Mar 24
2022 |
|
ANIP
|
Nikhil Lalwani
PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 100,055 Added 28.4% |
-
|
Mar 24
2022 |
|
ANIP
|
Stephen P. Carey
SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 33,875 Added 19.24% |
-
|
Mar 24
2022 |
|
ANIP
|
James G. Marken
SVP OPS & PROD DEV |
BUY
Grant, award, or other acquisition
|
Direct | 19,934 Added 13.14% |
-
|
Mar 24
2022 |
|
ANIP
|
Ori Gutwerg
SVP, GENERICS |
BUY
Grant, award, or other acquisition
|
Direct | 19,428 Added 38.4% |
-
|
Mar 24
2022 |
|
ANIP
|
Christopher Mutz
HEAD OF RARE DISEASE |
BUY
Grant, award, or other acquisition
|
Direct | 19,428 Added 36.11% |
-
|
Mar 24
2022 |
|
NRDS
|
Lauren St Clair
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 85,616 Added 27.03% |
-
|
Mar 24
2022 |
|
NRDS
|
Kelly Gillease
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 43,378 Added 20.75% |
-
|
Mar 24
2022 |
|
NRDS
|
Kevin Yuann
Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 34,246 Added 13.13% |
-
|
Mar 24
2022 |
|
FPI
|
Danny D. Moore
Director |
BUY
Grant, award, or other acquisition
|
Direct | 705 Added 13.03% |
$9,362
$13.28 p/Share
|
Mar 24
2022 |
|
FPI
|
Thomas Heneghan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 753 Added 3.35% |
$10,000
$13.28 p/Share
|
Mar 24
2022 |
|
POSH
|
Hans Tung
Director |
SELL
Open market or private sale
|
Indirect | 85,436 Reduced 2.08% |
$1,205,502
$14.11 p/Share
|
Mar 24
2022 |
|
ANF
|
Kristin A. Scott
President-Global Brands |
SELL
Payment of exercise price or tax liability
|
Direct | 19,629 Reduced 17.57% |
$611,640
$31.16 p/Share
|
Mar 24
2022 |